Merck has received approval for a new cholesterol-lowering drug.
Drugmaker Merck has received approval for the first-of-its-kind tablet capable of significantly reducing cholesterol levels in high-risk patients. This is considered an important step in the fight against cardiovascular diseases.
This new drug is especially designed to effectively lower cholesterol levels in individuals at high risk of developing cardiovascular diseases. Its approval is being hailed as a significant breakthrough in the medical field.
The approval of this innovative tablet creates new opportunities in the prevention and treatment of heart diseases associated with high cholesterol levels, and is expected to play a major role in improving patients' quality of life.
This was reported by The Guardian.